Former Domainex CEO Tom Mander and two colleagues have bought a 30-year-old life sciences company - Pharmagene Discovery ...

UKRI Research England has today published an independent report by Tony Hickson, Chief Business Officer at Cancer Research UK ...

Wellcome, which has substantial interests in Cambridge, has awarded £5.3 million to Wysa to fund a scale-up study that will adapt a clinically validated digital mental health intervention for ...

AstraZeneca, which has just launched on the New York Stock Exchange in addition to its London and Stockholm listings, is ...

Law firm Howes Percival has confirmed its Milton Keynes office will move to The Pinnacle on Midsummer Boulevard in April from ...

Marshall Aerospace and Nordiq Products have begun an industrial cooperation project to support the development and path to ...

Three of the four winners in the latest Trinity Bradfield Prize in Cambridge were CleanTech plays and the fourth has eco ...

Cambridge headquartered life science giant AstraZeneca has made a sensational bow on Wall Street, opening at $187.50 a share and soon sailing past $191.22p for an intra-day market cap of $591.712 ...

A $5.3 billion deal that sent interest soaring in the AI global cyber security sector just 15 months ago when Thoma Bravo in ...

The life sciences outlook for 2026 is being shaped by three interlocking forces, writes Paul Hughes, Managing Director, Life ...

Wellcome Sanger Institute Senior Group Leader, and former Institute Director, Professor Sir Mike Stratton has been awarded ...

The UK biotech sector continues to demonstrate a quiet but determined resilience, even as investors navigate more cautious ...